创新医疗
(002173)
| 流通市值：95.33亿 | | | 总市值：101.05亿 |
| 流通股本：4.16亿 | | | 总股本：4.41亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 249,045,212.83 | 163,567,040.65 | 137,984,131.56 | 547,164,141.38 |
| 交易性金融资产 | 213,134,328.8 | 234,047,088.12 | 287,799,259.39 | 13,251,406.5 |
| 应收票据及应收账款 | 74,886,592.5 | 128,385,494.42 | 124,184,225.79 | 111,110,613.96 |
| 应收账款 | 74,886,592.5 | 128,385,494.42 | 124,184,225.79 | 111,110,613.96 |
| 预付款项 | 4,227,450.08 | 4,631,423.46 | 4,649,527.59 | 3,359,624.47 |
| 其他应收款合计 | 2,237,697.77 | 1,984,981.78 | 1,263,450.56 | 2,459,106.47 |
| 存货 | 29,748,742.63 | 33,351,878.23 | 42,006,581.47 | 38,960,002.85 |
| 其他流动资产 | 1,131,270.55 | 978,399.07 | 965,364.63 | 1,396,479.65 |
| 流动资产合计 | 574,411,295.16 | 566,946,305.73 | 598,852,540.99 | 717,701,375.28 |
| 非流动资产: | | | | |
| 长期股权投资 | 38,917,276.56 | 39,648,629.81 | 41,746,715.83 | 13,101,441.86 |
| 固定资产 | 1,226,048,532.92 | 1,226,426,606.28 | 1,239,794,066.87 | 1,259,849,268.92 |
| 在建工程 | 10,689,264.52 | 9,967,610.39 | 9,451,323.39 | 3,745,623.56 |
| 使用权资产 | 19,751,191.36 | 22,007,238.9 | 24,158,795.46 | 26,668,744.49 |
| 无形资产 | 124,140,440.65 | 125,898,902.6 | 127,413,695.7 | 129,505,154.05 |
| 商誉 | 986,746.86 | 986,746.86 | 986,746.86 | 986,746.86 |
| 长期待摊费用 | 31,342,137.56 | 29,921,910.49 | 31,837,743.67 | 34,712,750.31 |
| 递延所得税资产 | 24,260,786.79 | 24,783,186.59 | 24,792,494.45 | 19,577,031.11 |
| 其他非流动资产 | 103,742,205.47 | 117,454,468.75 | 104,913,585.19 | 14,148,327.62 |
| 非流动资产合计 | 1,579,878,582.69 | 1,597,095,300.67 | 1,605,095,167.42 | 1,502,295,088.78 |
| 资产总计 | 2,154,289,877.85 | 2,164,041,606.4 | 2,203,947,708.41 | 2,219,996,464.06 |
| 流动负债: | | | | |
| 短期借款 | 46,051,332.62 | 46,056,465.96 | 41,056,466.06 | 41,051,332.73 |
| 应付票据及应付账款 | 174,414,919.5 | 187,395,167.34 | 195,242,664.18 | 191,933,745.75 |
| 其中：应付票据 | - | - | 1,000,000 | - |
| 应付账款 | 174,414,919.5 | 187,395,167.34 | 194,242,664.18 | 191,933,745.75 |
| 预收款项 | 152,083.34 | 152,083.34 | 163,083.34 | 38,357.94 |
| 合同负债 | 4,932,635.81 | 4,542,201.54 | 3,576,849.58 | 3,134,146.92 |
| 应付职工薪酬 | 33,336,059.86 | 32,131,611.95 | 47,015,597.16 | 33,952,172.63 |
| 应交税费 | 4,582,538.55 | 3,609,909.35 | 8,591,645.76 | 6,967,926.12 |
| 其他应付款合计 | 14,933,061.7 | 15,695,344.86 | 13,567,380.05 | 13,601,991.82 |
| 一年内到期的非流动负债 | 9,699,026.07 | 10,094,471.51 | 11,983,473.22 | 15,832,231.32 |
| 其他流动负债 | 11,504.42 | 11,504.42 | 11,504.42 | - |
| 流动负债合计 | 288,113,161.87 | 299,688,760.27 | 321,208,663.77 | 306,511,905.23 |
| 非流动负债: | | | | |
| 长期借款 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 |
| 租赁负债 | 10,890,131.79 | 10,992,011.45 | 15,139,272.49 | 13,744,414.1 |
| 预计负债 | 34,501,676.43 | 34,964,602.39 | 34,930,425.21 | 445,814.13 |
| 递延收益 | 3,236,621.91 | 43,796,077.84 | 3,547,340.25 | 3,702,699.42 |
| 递延所得税负债 | 43,641,374.52 | 3,391,981.08 | 44,023,165.01 | 44,201,376.76 |
| 非流动负债合计 | 100,269,804.65 | 101,144,672.76 | 105,640,202.96 | 70,094,304.41 |
| 负债合计 | 388,382,966.52 | 400,833,433.03 | 426,848,866.73 | 376,606,209.64 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 441,284,352 | 441,284,352 | 441,284,352 | 441,284,352 |
| 资本公积 | 2,708,003,168.7 | 2,708,003,168.7 | 2,708,003,168.7 | 2,708,003,168.7 |
| 盈余公积 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 |
| 未分配利润 | -1,409,553,038.17 | -1,412,129,160.15 | -1,398,191,741.89 | -1,332,081,858.74 |
| 归属于母公司股东权益合计 | 1,764,836,788.89 | 1,762,260,666.91 | 1,776,198,085.17 | 1,842,307,968.32 |
| 少数股东权益 | 1,070,122.44 | 947,506.46 | 900,756.51 | 1,082,286.1 |
| 股东权益合计 | 1,765,906,911.33 | 1,763,208,173.37 | 1,777,098,841.68 | 1,843,390,254.42 |
| 负债和股东权益合计 | 2,154,289,877.85 | 2,164,041,606.4 | 2,203,947,708.41 | 2,219,996,464.06 |
| 公告日期 | 2025-08-09 | 2025-04-28 | 2025-04-12 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |